Board Director for Curia, Medline, Ortho Clinical Diagnostics, PPD (former), Resonetics, Sedgwick, and others
Steve Wise is a Carlyle Managing Director and Head of Global Healthcare for Americas private equity. He is based in New York. Since joining Carlyle in 2006, Steve has led or been a key contributor to several Carlyle investments including Curia Global, CorroHealth, Medline, MedRisk HoldCo, LLC, MultiPlan, Inc., Millicent Pharma Limited, QuidelOrtho Corporation, Pharmaceutical Product Development, Inc., Rede D’Or São Luiz S.A., Resonetics, TriNetX, LLC, Unchained Labs and WellDyneRx, LLC. Prior to joining Carlyle, Steve worked with JLL Partners, a New York‐based private equity firm, where he focused on healthcare‐related investments. Previously, he worked with J.W. Childs Associates, a Boston‐based private equity firm, and prior to that, in the leveraged finance group of Credit Suisse. Steve serves as a director on the boards of Curia Global, CorroHealth, Medline, MedRisk HoldCo, LLC, Millicent Pharma Limited, QuidelOrtho Corporation, Rede D’Or São Luiz S.A., Resonetics, TriNetX, LLC, Unchained Labs, and WellDyneRx, LLC. Steve also serves on the Leadership Council of the Harvard School of Public Health. Steve received his M.B.A. from Harvard Business School and a B.A. in economics and finance from Bucknell University.